Slides
Page 1
INVESTOR PRESENTATION Second quarter ended June 27, 2026
Page 2
Forward-Looking Statements and use of financial measures not in accordance with IFRS This presentationcontains“forward-lookinginformation”,and the Corporation’soraland writtenpubliccommunicationsthat do not constitutehistoricalfactmay be deemedto be “forward-lookinginformation”withinthe meaningof applicableCanadiansecuritieslaw. Theseforward-lookingstatementsinclude,but are not limitedto, statementson the Corporation’sobjectivesand goalsand are basedon currentexpectations,projections,beliefs,judgments, and assumptionsbasedon informationavailableat the timethe applicableforward-lookingstatementwasmadeandconsideringthe Corporation’sexperiencecombinedwithits perceptionof historicaltrends. Forward-lookingstatementsare typicallyidentifiedby wordssuch as “anticipate”,“continue”,“estimate”,“expect”,“may”,“will”,“project”,“should”,“could”,“would”,“believe”,“plan”,“intend”,“design”,“target”,“objective”,“strategy”, “likely”,“potential”,“outlook”,“aim”,“goal”,and similarexpressionssuggestingfutureeventsor futureperformancein additionto the negativeformsof thesetermsor any variationsthereof. All statementsotherthanstatementsof historicalfactincludedin thisdocumentmay constitutea forward-lookingstatement. In this document,forward-lookingstatementsinclude,but are not limitedto, thoseset forth in Section6 – “Outlook”hereafteras well as to the statementsset forth in Section13 – “ShareRepurchasePlan” of the MD&A for the secondquarterendedJune 27, 2026, relatedto the Corporation’sintentionto launcha normalcourseissuerbid,the receiptof TorontoStockExchangeapprovaland the numberof sharethat may be repurchased. Suchforward looking statementsare based on several assumptions,including (i) the absence of any escalationin existing geopoliticaltensions or in trade-related measures, including tariffs, duties, and other trade restrictionsand countermeasures(collectivelyreferred to as “Tariffs”),and no adverse change in their current macroeconomiceffects; (ii) a relativelystable exchangerate between the U.S. dollar and the Canadian dollar; (iii) no further deteriorationof recentlyobservedconsumerbehavioursand market trendsfor the categoryof the Corporation’sproducts; (iv) the effectivenessof the Corporation’ssellingprice adjustmentinitiatives,with a limitedimpact on productdemand; (v) no materialdisruptionto the Corporation’soperations(includingworkforceavailability)or to its supplychain; (vi) the continuityof competitivetrendsobservedto date and the effectivenessof the Corporation’s strategyto positionitselfcompetitivelyin the marketsin whichit operates; (vii)limitedadditionalcostincreasesfrom suppliers; and (viii)adequateavailabilityof key raw materialsand packaginginputs. The outlookfurtherassumes the continuationof normalizedthroughputlevels at key manufacturingfacilities; expectedlead times for new manufacturingequipment; and sufficientavailabilityof contractorsand consultantsto support the executionof the Corporation’scapitalexpenditureprogram. In preparingits outlook,the Corporationmade assumptionsthat do not considerextraordinaryeventsor circumstancesbeyondits control. The Corporationbelievesthe expectations reflectedin theseforward-lookingstatementsare reasonable,but no assurancecan be giventhattheseexpectationswillproveto be correct,andsuchforward-lookingstatementsshouldnot be undulyreliedupon. and no adverse changein theircurrentmacroeconomiceffects; (ii)a relativelystableexchangeratebetweenthe U.S. dollarand the Canadiandollar; (iii)no furtherdeteriorationof recentlyobservedconsumerbehavioursand markettrendsfor the categoryof the Corporation’sproducts; (iv) the effectivenessof the Corporation’ssellingprice adjustmentinitiatives,with a limitedimpacton productdemand; (v) no materialdisruptionto the Corporation’soperations(including workforceavailability)or to its supplychain; (vi) the continuityof competitivedynamicsobservedto date and the effectivenessof the Corporation’sstrategyto positionitselfcompetitivelyin the marketsin whichit operates; (vii) limitedadditionalcostincreasesfromsuppliers; and(viii)adequateavailabilityof key raw materialsand packaginginputs. The outlookfurtherassumesthe continuationof normalizedthroughputlevelsat key manufacturingfacilities; expectedlead timesfor new manufacturingequipment; and sufficientavailabilityof contractorsand consultantsto supportthe executionof the Corporation’scapitalexpenditureprogram. In preparingits outlook,the Corporation madeassumptionsthatdo not considerextraordinaryeventsor circumstancesbeyondits control. The Corporationbelievesthe expectationsreflectedin theseforward-lookingstatementsare reasonable,but no assurancecan be giventhattheseexpectationswillproveto be correctand suchforward-lookingstatementsshouldnot be undulyreliedupon. Someof the forward-lookingstatementsin thisdocument,such as statementsconcerningsales,key commodityand inputcosts,effectivetax rate,workingcapitaland capitalexpendituresmay be consideredfinancialoutlooksfor the purposesof applicableCanadiansecuritiesregulations. Thesefinancialoutlooksare presentedto evaluatepotentialfutureearningsand anticipatedfutureusesof cashflowsandmay not be appropriatefor otherpurposes. Variousfactorsor assumptionsare appliedby the Corporationin elaboratingthe forward-lookingstatements. Thesefactorsand assumptionsare basedon informationcurrentlyavailableto the Corporation,includinginformation obtainedby the Corporationfromthirdparties. Readersarecautionedthatthe assumptionsconsideredby the Corporationto supporttheseforward-lookingstatementsmayproveto be incorrectin wholeor in part. 2
Page 3
Forward-Looking Statements and use of financial measures not in accordance with IFRS (cont’d) The significant factors that could cause actual results to differ materially from the conclusions, forecasts or projections reflected in the forward-looking statements contained herein include, among other things and without limitations, risks associated with the following: deterioration of general macroeconomic or socioeconomic conditions, including ongoing conflicts, trade and industrial policy frictions among major global economies and the increased use of economic sanctions (including tariffs, duties and other trade restrictions), which can lead to negative impacts on the Corporation’s suppliers, customers and operating costs; the availability of raw materials and packaging and related price variations, more specifically for the Corporation’s key commodities together with the effectiveness of its related hedging strategies; the ability to adapt to changes and developments affecting the Corporation’s industry, including customer preferences, tastes, and buying patterns, market conditions, retail dynamics, the potential for consumer purchasing decisions to be influenced by perceived social or political alignment in the context of trade conflicts and the activities of competitors and customers; the risk that competitors may have access to better technology, including artificial intelligence and digital marketing capabilities; disruptions in, failures of, or cybersecurity threats targeting the Corporation’s information technology systems leading to business disruptions, compromised data integrity, confidentiality breaches, or business email compromise related fraud; the successful deployment of the Corporation’s multi-year strategy (the “Strategy”, defined in Section 4 – “Multi Year Strategy” of the annual MD&A for the year ended December 31, 2025), including the successful execution of its key capital projects along with the materialization of the underlying expected benefits; dependence on licensed or third-party brand arrangements that are subject to renewal, termination, or modification by the brand owner, where any adverse change could result in lost sales or additional costs; the ability to revitalize the performance of the Corporation’s U.S. beverage subsidiaries; climate change and disasters causing higher operating costs and capital expenditures and reduced production output, or impacting the availability, quality or price volatility of key commodities sourced by the Corporation; the potential for work stoppages due to the non-renewal or the inability to conclude collective bargaining agreements or other reasons; the Corporation’s ability to effectively integrate any acquisitions; loss of or disputes with key suppliers or supplier concentration; changes made to laws and rules that affect the Corporation’s activities, particularly in matters of tax, as well as the interpretation thereof, and new positions adopted by relevant authorities; the Corporation’s ability to maintain strong sourcing and manufacturing platforms and efficient distribution channels; fluctuations in the prices of inbound and outbound freight, the impact of oil prices (and derivatives thereof) on the Corporation’s direct and indirect costs along with the Corporation’s ability to transfer those increases through higher prices or other means, if any, to its customers in competitive market conditions and considering demand elasticity; the successful deployment of the Corporation’s health and safety programs in compliance with applicable laws and regulations; serious injuries or fatalities, which could have a material impact on the Corporation’s business continuity and reputation and lead to compliance-related costs; the scarcity of labour and the related impact on the hiring, training, developing, retaining and reliance of personnel together with their productivity, employment matters, compliance with employment laws across multiple jurisdictions; the increasing concentration of customers in the food industry, providing them with significant bargaining power, particularly on the Corporation’s selling prices; the implementation, cost, and impact of environmental sustainability initiatives, as well as the cost of remediating environmental liabilities; failure to maintain the quality and safety of the Corporation’s products, which could result in product recalls and product liability claims for misbranded, adulterated, contaminated, or spoiled food products, along with reputational damage; risks associated with the Corporation’s use of artificial intelligence-enabled tools; risks related to fluctuations in interest rates, currency exchange rates, liquidity and credit, stock price and pension obligations; the incurrence of restructuring, disposal, or other related charges together with the recognition of impairment charges on goodwill or long-lived assets; the sufficiency of insurance coverage; and the implications and outcome of potential legal actions, litigation or regulatory proceedings to which the Corporation may be a party. The Corporation cautions readers that the foregoing list of factors is not exhaustive. The Corporation’s ability to achieve its sustainability priorities, targets and goals is further subject to, among other factors, its ability to access and implement all technology necessary to achieve them; the development, deployment, and performance of technology and industry-specific solutions; environmental regulation; the availability, accessibility and suitability of comprehensive and high-quality data; and changes in standards or methodologies used. The Corporation’s ability to achieve its sustainability priorities, targets and goals is further subject to, among other factors, its ability to leverage its supplier relationships. Assumptions, expectations, and estimates involved in preparing forward-looking statements and risks and uncertainties that could cause actual results to differ materially from forward-looking statements are discussed in the Corporation’s materials filed with the Canadian securities regulatory authorities, including information about risk factors that can be found in Section 19 – “Uncertainties and Principal Risk Factors” of the annual MD&A for the year ended December 31, 2025. Readers should review this section in detail. All forward-looking statements included herein are made as of the date hereof. Unless required by law, the Corporation does not undertake any obligation to publicly update or revise forward-looking statements, whether as a result of new information, future events, or otherwise. All forward-looking statements contained herein are wholly and expressly qualified by this cautionary statement. This document contains financial measures not in accordance with IFRS. Lassonde reports its financial results in accordance with IFRS and generally assesses its financial performance using financial measures or ratios that are prepared using IFRS. However, this MD&A also refers to certain measures or ratios that are not in accordance with IFRS. Refer to Section 16 – “Financial Measures Not in Accordance With IFRS” of the MD&A for the second quarter ended June 27, 2026 for more information, including the definition and composition of the measure or ratio as well as the reconciliation to the most comparable measure in the financial statements, as applicable. These measures may not be comparable to similar measures presented by other issuers. These metrics are presented as a complement to enhance the understanding of Lassonde’s financial performance by providing investors with supplemental metrics including metrics to assess and measure its operating performance and financial position from one period to the next but are not in substitution of IFRS measures. In addition, measures that are not in accordance with IFRS should not be viewed as a substitute to the related financial information prepared in accordance with IFRS. 3
Page 4
Strong Gross Profit Growth in Q2 Effective revenue management Improved product mix Moderating input costs Solid execution of our business strategy Our diversified portfolio performed well ▪ Underscoring its strength and resilience 4
Page 5
U.S. Beverage Our private label products outperformed the category ▪ Regaining some of the distribution temporarily affected by earlier supply constraints ▪ Disciplined approach to revenue management Expanded volumes secured under the build-back plan with several existing and new customers ▪ Maintained contractual commitments with most others Our branded business had a solid quarter ▪ Distribution gains for Apple & Eve in U.S. Mid-West and West ▪ Methodically expanding its reach in single-serve and juice box formats, supported by our investments in these platforms Pace of construction in New Jersey progressing on schedule ▪ Equipment installation underway ▪ On track to gradually begin transferring existing production in late 2026, to be completed in the first half of 2027 5
Page 6
Canadian Beverage Maintained our category leadership ▪ Despite cycling strong prior-year period due to “Buy Canadian” and lower category volume ▪ Underscores the strength of our portfolio National brands continued to outpace the category ▪ Solid gains in shelf-stable products ▪ Sustained momentum on single-serve formats ▪ Chilled products affected by strong prior-year comparison Private labels were softer ▪ Changes in a customer’s go-to-market strategy ▪ Discontinuation of selected product lines Focused on disciplined revenue management Innovation as a lever for improving product mix ▪ Developing new formulations and single-serve formats ▪ Expanding our presence in growth segments, reducing commodity exposure and enhancing profitability 6
Page 7
Food Service Continued to build meaningful traction with U.S. broadline distributors ▪ Primarily by expanding private label beverage offerings in different pack formats “Bag-in-a-box” aseptic packaging line ▪ Began supplying tailored beverages to a prominent Canadian-based QSR chain ▪ Initial results exceeded expectations ▪ Actively engaged in negotiations and bidding processes with national and regional partners across North America 7
Page 8
Specialty Food Both our Canadian and U.S. operations delivered solid gains ▪ Driven by core premium and super-premium pasta sauce categories ▪ Despite lower industry volumes in our key product categories Summer Garden increased volumes for third-party pasta sauces G. Hughes maintained its #1 position in U.S. Better-For-You ▪ Brand refresh completed internally; new packaging at manufacturing level ▪ New positioning to further support the brand in H2-2026 Distribution gains for G. Hughes in Canada ▪ Expanded distribution with a mass merchant ▪ Secured new distribution with a national food retailer Solid performance by our Canadian operations ▪ Growing third-party brand volume ▪ Distribution gains for pasta sauces ▪ Share gains in the ready-to-serve soup category 8
Page 9
Q2 2026 Sales ($M) Key Highlights ✓ FX impact: ▼ $0.7M ✓ Down 0.5% excluding FX ✓ Effect of sales volume (mainly Canada): ▼ $21.1M ▼ $11.8M private labels, including ~ $8M from portfolio optimization ▼ $9.3M national brands ✓ Selling price adjustments (mainly U.S.): ▲ $9.7M ▲ $5.6M private labels ▲ $4.1M national brands ✓ Changes in sales mix (mainly Canada): ▲ $4.8M 9 2025 2026 (1%) $742.4 $737.7
Page 10
Q2 2026 Profitability Gross Profit ($M) Operating Profit ($M) Adjusted EBITDA(1) ($M) (1) Financial measure not in accordance with IFRS. Please refer to section on Financial Measures Not in Accordance with IFRS. 10 2025 2026 +16% 2025 2026 (27%) 26.4% 7.3% 5.4% $195.7 $227.6 $54.4 $40.0 $84.4 $100.7 2025 2026 +19% 11.4% 13.7%30.8% Key Highlights Higher gross profit ✓ Decrease in the cost of orange concentrates ✓ Favourable impact of selling price adjustments ✓ Positive shift in the sales mix Partly offset by: ✓ Lower sales volume ✓ Higher PET resin cost Higher SG&A expenses ✓ Higher transportation costs to deliver products to clients ✓ Higher performance-related compensation expenses ✓ Increase in certain administrative expenses Impairment charges of $30.2M ✓ Including $27.4M on a customer relationship intangible asset due to contractual changes (U.S. Specialty Food)
Page 11
Q2 2026 Profitability (cont’d) Profit Attributable to the Shareholders ($M) & EPS Adjusted Profit Attributable to the Shareholders(1) ($M) & Adjusted EPS(1) (1) Financial measure not in accordance with IFRS. Please refer to section on Financial Measures Not in Accordance with IFRS. 11 $37.2 $50.8 2025 2026 +36% $5.47 $7.45 $34.3 $26.9 2025 2026 (22%) $5.03 $3.95
Page 12
Q2 2026 Days Operating Working Capital (1) (1) Financial measure not in accordance with IFRS. Please refer to section on Financial Measures Not in Accordance with IFRS 12 Should remain within historical range in 2026 23 22 17 20 20 84 85 78 87 85 36 40 42 44 48 59 59 43 51 46 0 10 20 30 40 50 60 70 80 90 100 Q2-17 Q2-18 Q2-19 Q2-20 Q2-21 Q2-22 Q2-23 Q2-24 Q2-25 Q3-25 Q4-25 Q1-26 Q2-26 Days DSO (1) DIO (1) DPO (1) Days Operating W/C (1) Within normal seasonal range
Page 13
Q2 2026 Cash Flows ($M) 13 Key Highlights ✓ Higher operating cash flows in Q2-2026 ▪ Lower working capital requirement this year compared to last ✓ CAPEX of $37.5M in Q2-2026 ✓ 2026 CAPEX expected to reach up to 7% of sales ▪ ~ US$96M for the NJ facility 2025 2026 2025 2026 ($3.1) $77.8 $28.0 $37.5 Acquisitions of PP&E and Intangible Assets Operating Activities
Page 14
2.03x 1.71x 1.42x 1.35x 1.22x 0 150 300 450 600 750 June 28, 2025 Sept. 27, 2025 Dec. 31, 2025 March 28, 2026 June 27, 2026 Net Debt Net Debt to Adjusted EBITDA $474.2 $618.1 $549.5 $489.3 $451.4 $595.5 $504.0 $444.6 $433.1 $407.7 $187.3 $197.0 $226.1 $235.4 $221.0 June 28, 2025 Sept. 27, 2025 Dec. 31, 2025 March 28, 2026 June 27, 2026 Long-term Debt Trailing 12-mo. Operating Profit (1) Q2 2026 Financial Position ($M) Ratio to remain well below internal maximum threshold of 3.25x (1) Including the current portion. (2) Financial measure not in accordance with IFRS. Please refer to section on Financial Measures Not in Accordance with IFRS. 14 (2)(2)
Page 15
Intention to Launch a Normal Course Issuer Bid (NCIB) To purchase for cancellation up to 200,000 common shares over a 12-month period Represents approximately 6.5% of the issued and outstanding Class A subordinate voting shares Launch is subject to TSX approval 15
Page 16
2026 Outlook Focus on executing our Strategy ▪ Strengthening the competitive position of our brands ▪ Accelerating our innovation agenda ▪ Ensuring the readiness of our New Jersey facility Macroeconomic and geopolitical environment remains challenging ▪ Potential implications for consumer spending, input costs and supply dynamics Leverage the strength, depth and breadth of our portfolio ▪ Balanced contribution from revenue management and volume growth Expect 2026 sales to be slightly below last year’s level ▪ Excluding foreign exchange impacts and any major external disruptions ▪ Prioritize profitable sales over volume growth 16
Page 17
Strategic Priorities U.S. Beverage ▪ Leverage investments in single-serve and juice box lines ▪ Maintain disciplined revenue management ▪ Complete the construction of the New Jersey facility Canadian Beverage ▪ Innovation-led growth initiatives ▪ Maintain disciplined revenue management ▪ Strengthen execution in core channels Food Service ▪ Pursue growth opportunities, including “bag-in-a-box” platform Specialty Food ▪ Optimize the integration of our North American network ▪ Refine the positioning of branded products ▪ Backfill available capacity following contractual changes with a customer ▪ Secured replacement volume for more than 50% of expected 2027 shortfall ▪ Advanced negotiations for another 25% ▪ Strengthens our position by diversifying customer base and product portfolio 17
Page 18
Key Commodities and Input Costs Costs ▪ Orange concentrate and, to a lesser extent, apple concentrate costs should be less than last year ▪ Middle East situation adding inflationary pressure to transportation and PET resin costs We are focused on the levers we can manage ▪ Reducing our commodity exposure through product mix optimization and innovation ▪ Maintaining pricing discipline ▪ Executing targeted cost initiatives to protect margins ▪ Network flexibility allows us to optimize production and distribution flows ▪ Reassess and adapt our strategies as conditions evolve 18
Page 19
Conclusion Well positioned to navigate near-term challenges ▪ Focused on advancing our long-term strategy Intent to launch NCIB(1) reflects confidence in our long-term prospects and our belief that our shares are undervalued ▪ Compelling investment in the business ▪ Effective way to create value for shareholders Continue investing in the capabilities that will drive sustainable and profitable growth supported by: ▪ A diversified portfolio of leading brands ▪ Deep customer relationships ▪ Disciplined execution by our dedicated teams 19 (1) Subject to TSX approval.
Page 20
Financial Measures Not in Accordance with IFRS
Page 21
Financial Measures Not in Accordance with IFRS Items impacting the comparability between periods The table on the right contains a list, description and quantification of items impacting the comparability of the financial performance between the periods. EBITDA and Adjusted EBITDA EBITDA is a financial measure used by the Corporation and investors to assess the Corporation’s capacity to generate future cash flows from operating activities and pay financial expenses. Adjusted EBITDA is a financial measure used by the Corporation to compare EBITDA between periods by excluding items impacting comparability. EBITDA consists of the sum of operating profit and of the “depreciation of right-of-use assets and property, plant and equipment and amortization of intangible assets” item and the “(Gains) losses on capital assets,” item, as shown in the Consolidated Statement of Cash Flows. Adjusted EBITDA is calculated by adjusting the EBITDA with items considered by management as impacting the comparability between periods. The most directly comparable IFRS measure is the operating profit. EBITDA as a percentage of sales EBITDA as a percentage of sales is a financial measure used by the Corporation and investors to compare business units or companies across industries, especially those with different tax rates or capital structures. EBITDA as a percentage of sales is calculated by dividing the EBITDA by sales. 21
Page 22
Financial Measures Not in Accordance with IFRS (cont’d) 22 Adjusted Profit Attributable to the Corporation’s Shareholders and Adjusted EPS Adjusted profit attributable to the Corporation’s shareholders is a financial measure and adjusted EPS (composed notably of Adjusted profit attributable to the Corporation’s shareholders) is a financial ratio that are used by the Corporation and investors to compare profit attributable to the Corporation’s shareholders and EPS between periods by excluding items impacting comparability. They are calculated by adjusting them with items considered by management as impacting the comparability between periods. The most directly comparable IFRS measures are the profit attributable to the Corporation’s shareholders and the EPS. Net Debt and Net Debt to Adjusted EBITDA Net debt is a financial measure and Net debt to adjusted EBITDA is a financial ratio that are used by the Corporation to assess its ability to pay off existing debt and define available borrowing capacity. To calculate the net debt to adjusted EBITDA ratio, net debt is divided by the sum of adjusted EBITDA from the last four quarters. Net debt represents the sum of lease liabilities, including the current portion and of long-term debt, including the current portion, less the “Cash and cash equivalents” item, as they are presented in the Corporation’s Consolidated Statement of Financial Position. The most directly comparable IFRS measures are long-term debt, including the current portion, and operating profit.
Page 23
Financial Measures Not in Accordance with IFRS (cont’d) 23 Operating Working Capital and Days Operating Working Capital is a financial measure and days operating working capital is a financial ratio that are used by the Corporation to monitor the efficiency of its working capital management and the amount of capital invested in day-to-day operations. Operating working capital consists of the current assets, less the “Cash and cash equivalents” item, income tax recoverable, derivative instruments (current) and other current assets, as they are presented in the Corporation’s Consolidated Statement of Financial Position and less other receivables, trade payables and accrued expenses and trade spending as they are presented in the accompanying notes to the Corporation’s interim consolidated financial statements. To calculate days operating working capital, operating working capital is divided by the last quarter’s sales, as they are presented in Section 7 – “Analysis of the Consolidated Results” of the MD&A for the second quarter ended June 27, 2026, and multiplied by 91 days. The most directly comparable IFRS measures are current assets and current liabilities. Days of Sales Outstanding (“DSO”) is a financial ratio used by the Corporation to represent the average number of days that it takes the Corporation to collect payment for a sale. This ratio is obtained by dividing accounts receivable, as they are presented in the Corporation’s Consolidated Statement of Financial Position, less discounts receivable, other receivables and trade spending, as they are presented in the accompanying notes to the Corporation’s interim consolidated financial statements, by the last quarter’s sales, as they are presented in Section 7 – “Analysis of the Consolidated Results” of the MD&A for the second quarter ended June 27, 2026, and multiplied by 91 days. The most directly comparable IFRS measures is the accounts receivable. Days of Inventory Outstanding (“DIO”) is a financial ratio used by the Corporation to represent the average number of days the Corporation takes to turn its inventory into sales. To calculate this ratio, inventories, as they are presented in the Consolidated Statement of Financial Position, are divided by the last quarter’s cost of sales, as it is presented in Section 7 – “Analysis of the Consolidated Results” of the MD&A for the second quarter ended June 27, 2026, and multiplied by 91 days. Days of Payable Outstanding (“DPO”) is a financial ratio used by the Corporation to represent the average number of days the Corporation takes to pay its accounts payable and accrued liabilities. This ratio is obtained by dividing accounts payable and accrued liabilities, as they are presented in the Consolidated Statement of Financial Position, less trade spending, salaries and accrued vacation payable, other accounts payable and accrued liabilities and discounts receivable, as they are presented in the accompanying notes to the Corporation’s interim consolidated financial statements, by the last quarter’s cost of sales, as it is presented in Section 7 – “Analysis of the Consolidated Results” of the MD&A for the second quarter ended June 27, 2026, and multiplied by 91 days. The most directly comparable IFRS measures is the accounts payable and accrued liabilities.
Page 24
Key Information
Page 25
Financial Highlights 25 (1) This measure does not constitute a standardized financial measure in accordance with the financial reporting framework used to prepare the Corporation's financial statements. Comparing it to a similar financial measure presented by other issuers may not be possible. Refer to Section 16 – “Financial Measures Not in Accordance With IFRS” of the MD&A for the second quarter ended June 27, 2026, for more information.
Page 26
Sales Evolution 26
Page 27
Evolution – Frozen Concentrate Orange Juice Source: Trading Economics 27
Page 28
Evolution – Apple Juice Concentrate Source: US Department of Agriculture 28